Trading Ideas Archives - Page 26 of 3111

4 minute read

Investigating Advanced Micro Devices’s Standing In Semiconductors & Semiconductor Equipment Industry Compared To Competitors

June 17, 11:00 AM

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for…

AMD

2 minute read

Peering Into Golden Heaven Group Hldgs’s Recent Short Interest

By Benzinga Insights

June 17, 11:00 AM

Golden Heaven Group Hldgs’s (NYSE:GDHG) short percent of float has risen 39.43% since its last report. The company…

GDHG

4 minute read

In-Depth Analysis: ON Semiconductor Versus Competitors In Semiconductors & Semiconductor Equipment Industry

By Benzinga Insights

June 17, 11:00 AM

In today’s fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze…

1 minute read

$1000 Invested In United Airlines Holdings 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

June 17, 11:00 AM

United Airlines Holdings (NASDAQ:UAL) has outperformed the market over the past 15 years by 7.26% on an annualized…

UAL

2 minute read

How Is The Market Feeling About Citizens Financial Group?

By Benzinga Insights

June 17, 11:00 AM

Citizens Financial Group’s (NYSE:CFG) short percent of float has fallen 35.64% since its last report. The company recently…

CFG

2 minute read

(MCK) – Analyzing McKesson’s Short Interest

By Benzinga Insights

June 17, 11:00 AM

McKesson’s (NYSE:MCK) short percent of float has fallen 13.07% since its last report. The company recently reported that…

MCK

1 minute read

Chainlink Falls More Than 4% In 24 hours

By Benzinga Insights

June 17, 11:00 AM

Over the past 24 hours, Chainlink's (CRYPTO: LINK) price has fallen 4.53% to $14.28. This continues its negative trend over the past week where it has experienced a 11.0% loss, moving from $16.0 to its current price.

LINK

1 minute read

Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies

By Vandana Singh

June 17, 10:53 AM

Mirum Pharmaceuticals announced promising interim results from Phase 2b studies of volixibat for primary biliary cholangitis and primary sclerosing cholangitis. Significant improvements in pruritus and fatigue were observed.

MIRM